文献速递甲状腺疾病

通过包含TAC、8-OHdG和Sortilin的生物标志物组合增强甲状腺乳头状癌血管侵袭评估

Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本研究为横断面研究,纳入50例血管侵袭性甲状腺乳头状癌患者(研究组)和30例低风险特征患者(参照组),分析血清8-OHdG、总氧化能力、总抗氧化能力(TAC)和sortilin与血管侵袭的关联。结果显示8-OHdG和sortilin显著升高、TAC显著降低(均P<.01),三者回归组合鉴别血管侵袭的曲线下面积为0.963。作者认为这些标志物可能有助于识别血管侵袭,但需进一步验证研究后才能常规临床应用。

要点

  • 血管侵袭性甲状腺乳头状癌患者血清8-OHdG和sortilin显著升高、TAC显著降低(均P<.01)。
  • TAC、8-OHdG和sortilin回归组合鉴别血管侵袭的曲线下面积为0.963。
  • 作者认为这些标志物可能辅助风险分层和个体化治疗决策,但需进一步验证研究。

核心结论

  • 测量TAC、8-OHdG和sortilin水平可能作为识别甲状腺乳头状癌血管侵袭的潜在生物标志物。
  • 这些生物标志物的联合评估增强血管侵袭鉴别,有助于风险分层和个体化治疗决策。
  • 在将这些生物标志物整合入常规临床实践之前,需要进一步验证研究。

研究设计与样本

  • 横断面研究,纳入50例血管侵袭性甲状腺乳头状癌患者(研究组)和30例低风险特征甲状腺乳头状癌患者(参照组)。
  • 患者招募自波兰比亚韦斯托克医科大学内分泌、糖尿病和内科疾病系。
  • 分析血清生物标志物水平以确定其与血管侵袭的关联。

主要发现

  • 血管侵袭性甲状腺乳头状癌患者血清8-OHdG和sortilin水平显著升高,而TAC显著降低(均P<.01)。
  • TAC、8-OHdG和sortilin组合的回归面板鉴别血管侵袭的曲线下面积为0.963。

关键数值与推荐

  • 研究组为50例血管侵袭性甲状腺乳头状癌患者,参照组为30例低风险特征甲状腺乳头状癌患者。
  • 主要结局指标包括血清8-OHdG、总氧化能力、TAC和sortilin水平。
  • 8-OHdG和sortilin升高、TAC降低均P<.01。
  • TAC、8-OHdG和sortilin回归组合的曲线下面积为0.963。

临床怎么用

  • 作者认为测量TAC、8-OHdG和sortilin水平可能作为识别甲状腺乳头状癌血管侵袭的潜在生物标志物。
  • 作者认为这些生物标志物的联合评估有助于风险分层和个体化治疗决策。
  • 作者指出在将这些生物标志物整合入常规临床实践之前需要进一步验证研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Papillary thyroid cancer (PTC) aggressiveness and metastatic potential are closely associated with angioinvasion. Identifying angioinvasion accurately is imperative for treatment planning and prognosis. OBJECTIVE: This study explores serum biomarkers, including 8-hydroxydeoxyguanosine (8-OHdG) and oxidative status markers (total oxidative capacity, total antioxidant capacity [TAC], and sortilin), as potential indicators of angioinvasion in PTC. DESIGN: A cross-sectional study involving 50 angioinvasive patients with PTC (study group) and 30 patients with PTC with low-risk features (reference group). Serum levels of biomarkers were analyzed to determine their association with angioinvasion. SETTING: Patients were recruited from Department of Endocrinology, Diabetology, and Internal Diseases, Medical University of Bialystok, Poland, ensuring representation from a diverse clinical context. PATIENTS OR OTHER PARTICIPANTS: Participants included patients with PTC, with 50 in the study group and 30 in the reference group. Selection criteria, matching characteristics, and participant completion rates were duly recorded. INTERVENTION(S): Serum biomarkers were measured to evaluate their association with PTC angioinvasion. MAIN OUTCOME MEASURE(S): Primary outcome measures included serum levels of 8-OHdG, total oxidative capacity, TAC, and sortilin. RESULTS: Serum levels of 8-OHdG and sortilin were significantly elevated in angioinvasive PTC, whereas TAC showed a notable decrease (all P < .01). A regression panel combining TAC, 8-OHdG, and sortilin demonstrated a high area under the curve value (0.963) for angioinvasion discernment. CONCLUSION: Measuring TAC, 8-OHdG, and sortilin levels may serve as potential biomarkers for identifying angioinvasion in PTC. The combined assessment of these biomarkers enhances angioinvasion discernment, aiding risk stratification and personalized treatment decisions. Further validation studies are required before integrating these biomarkers into routine clinical practice. The study adheres to the provided structure, providing concise and supported conclusions based on the results.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Buczyńska A, Kościuszko M, Sidorkiewicz I, et al. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin. J Clin Endocrinol Metab. 2024. PMID: 38181425. doi:10.1210/clinem/dgae007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。